BioSpace News Archive

Increasing prevalence of chronic diseases, rising demand for syringes and needles for therapy and drug delivery, and technological advancements are key factors fueling global market growth

Increasing demand for low volume sample analysis in diagnostics is a major factor driving market revenue growth

Increasing prevalence of chronic diseases, risk of high BP in elderly population, and growing awareness about early diagnosis are some key factors expected to drive global market growth

Castle Biosciences, Inc. (Nasdaq: CSTL), today announced new study data demonstrating the ability of its TissueCypher® Barrett’s Esophagus test to independently predict malignant progression to high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC) in patients with non-dysplastic (ND), indefinite or low-grade dysplasia (LGD) Barrett’s esophagus (BE).

Increasing prevalence of atrial fibrillation, advancements in AFib prediction and management, and improved precision in diagnosis of this condition are some key factors expected to drive market growth

Increasing prevalence of chronic diseases and digestive enzyme disorders, rapid technological advancements, and rising demand for effective therapeutics are some factors expected to drive global Specialty Enzymes market growth.

The latest market report presented by Reports and Data, titled “Healthcare Supply Chain Management Market By Product (Software, Hardware, Services), By Mode of Delivery (Cloud-Based, On-Premise), By End Use (Healthcare Manufacturers, Healthcare Providers, Distributors, Logistics), And By Region Forecasts to 2028” is inclusive of crucial data & information pertaining to the global Healthcare Supply Chain Management market.

Rising prevalence of chronic and acute diseases and rapidly growing geriatric population are among the major factors driving the global market revenue growth

Rising prevalence of various cancers including breast, lung, prostate and colon worldwide, rising number of cosmetic surgeries, and high preference for near-infrared imaging over conventional imaging methods are expected to drive global Near-Infrared Imaging market growth.

Yesterday, Governor Ned Lamont signed House Bill 5500 into law which includes provisions to establish a permanent Rare Disease Advisory Council in the state of Connecticut.